Peripheral nerve segmental loss injuries repaired with polyethylene glycol (peg)-fused allografts

The University of Texas at Austin received a $749,938 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with completion targeted for August 31, 2027. The award supports research on peripheral nerve segmental loss injuries repaired using polyethylene glycol (PEG)-fused allografts. This project delivers hypothesis-driven biomedical research and development services focused on innovative medical solutions for nerve repair injuries, with potential applications benefiting military service members and the broader public.

The research will be conducted in Austin, Texas, with Metis Foundation serving as a sub-awardee providing research coordination and scientific support services. The Military Medical Research and Development program funds basic, applied, and advanced biomedical research initiatives designed to transform healthcare through innovative medical solutions addressing critical health challenges. Awards under this program typically support research translation, clinical validation, and therapeutic development activities across medical domains including trauma care and medical device innovation, with performance periods generally spanning two to four years.